XML 29 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Financial Instruments
12 Months Ended
Jun. 24, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments [Text Block]
FINANCIAL INSTRUMENTS

Short-term investments
Fair values were as follows:
 
June 24, 2017
 
June 25, 2016
 
Amortized Cost
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Estimated Fair Value
 
Amortized Cost
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Estimated Fair Value
 
(in thousands)
Available-for-sale investments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. treasury bills
$
499,952

 
$

 
$
(1,234
)
 
$
498,718

 
$
124,950

 
$
489

 
$

 
$
125,439

Total available-for-sale investments
$
499,952

 
$

 
$
(1,234
)
 
$
498,718

 
$
124,950

 
$
489

 
$

 
$
125,439



In the fiscal years ended June 24, 2017 and June 25, 2016, the Company did not recognize any impairment charges on short-term investments. The U.S. treasury bills have maturity dates between December 15, 2017 and June 15, 2019.
Derivative instruments and hedging activities

The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and British Pound, Indian Rupee, Taiwan New Dollar, South Korean Won, and Chinese Yuan, expenditures for sales offices and research and development activities undertaken outside of the U.S.

The Company has established a program that exclusively utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.

Derivatives designated as cash flow hedging instruments

The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) No. 815-Derivatives and Hedging (“ASC 815”). As of June 24, 2017 and June 25, 2016, respectively, the notional amounts of the forward contracts the Company held to purchase international currencies were $36.2 million and $68.0 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0.2 million and $2.6 million, respectively.

Derivatives not designated as hedging instruments

As of June 24, 2017 and June 25, 2016, respectively, the notional amounts of the forward contracts the Company held to purchase international currencies were $44.5 million and $25.4 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.6 million and $24.6 million, respectively. The fair values of outstanding foreign currency forward contracts and gain (loss) included in the Consolidated Statements of Income were not material for the fiscal years ended June 24, 2017 and June 25, 2016.

Outstanding debt obligations
The following table summarizes the Company's outstanding debt obligations:
 
June 24,
2017
 
June 25,
2016
 
(in thousands)
3.450% fixed rate notes due June 2027
$
500,000

 
$

2.5% fixed rate notes due November 2018
500,000

 
500,000

3.375% fixed rate notes due March 2023
500,000

 
500,000

Short-term credit agreement

 
250,000

Total outstanding debt
1,500,000

 
1,250,000

 
 
 
 
Less: Current portion (included in “Current portion of debt”)

 
(249,717
)
Less: Reduction for unamortized discount and debt issuance costs
(12,322
)
 
(10,193
)
Total long-term debt
$
1,487,678

 
$
990,090



Long-term debt

On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.450% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5%. Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million, after issuing at a discount and deducting paid expenses.

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses.

The debt indentures that govern the 2027 Notes, the 2023 Notes and the 2018 Notes, respectively, include covenants that, under certain circumstances, limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes, the 2023 Notes or the 2018 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest.

The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes was $31.7 million, $29.4 million and $29.4 million during the years ended June 24, 2017, June 25, 2016, and June 27, 2015, respectively.

The estimated fair value of the Company's long-term debt was approximately $1,516 million as of June 24, 2017. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.

The Company recorded interest expense of $34.3 million, $32.7 million, and $32.5 million during the fiscal years ended June 24, 2017, June 25, 2016, and June 27, 2015, respectively.

Credit facilities
Revolving credit facility

The Company has access to a $350 million senior unsecured revolving credit facility with certain institutional lenders that expires on June 27, 2019. The facility fee is at a rate per annum that varies based on the Company's index debt rating and any advances under the credit agreement will accrue interest at a base rate plus a margin based on the Company's index debt rating. The credit agreement requires the Company to comply with certain covenants, including a requirement that the Company maintain a ratio of debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) of not more than 3 to 1 and a minimum interest coverage ratio (EBITDA divided by interest expense) greater than 3.5 to 1. As of June 24, 2017, the Company had not borrowed any amounts from this credit facility and was in compliance with all debt covenants.
Short-term credit agreement

On June 23, 2016, a wholly-owned foreign subsidiary of the Company entered into a short-term credit agreement (the “Credit Agreement”) with The Bank of Tokyo-Mitsubishi UFJ, Ltd. (the “Lender”), in order to facilitate the return of capital to the Company. The Credit Agreement provided for, among other things, the Lender making an unsecured term loan in an amount equal to $250 million and had a maturity date of June 22, 2017. On December 21, 2016, the $250 million aggregate principal amount and all outstanding interest on the loan were repaid.

Other financial instruments

For the balance of the Company's financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.